Does price disclosure in pharmaceutical advertising result in price transparency? Evidence from a randomized experiment
Background: Policies that mandate list price disclosure in direct-to-consumer pharmaceutical advertising (DTCPA) cite price transparency among the benefits. The expectation is that price transparency will lead to changes in consumer behavior that will ultimately lower healthcare costs. Objective: Th...
Sábháilte in:
Príomhchruthaitheoirí: | Ilene L. Hollin (Údar), Jennifer Gerard Ball (Údar) |
---|---|
Formáid: | LEABHAR |
Foilsithe / Cruthaithe: |
Elsevier,
2022-12-01T00:00:00Z.
|
Ábhair: | |
Rochtain ar líne: | Connect to this object online. |
Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Price-Transparency and Cost Accounting
de réir: Peter Hilsenrath PhD, et al.
Foilsithe / Cruthaithe: (2015) -
Mohs Surgery Price Transparency and Variability at Academic Hospitals After the Implementation of the Federal Price Transparency Final Rule
de réir: Neelesh P Jain, et al.
Foilsithe / Cruthaithe: (2023) -
Price transparency in Iranian healthcare market
de réir: Ameneh Rahban, et al.
Foilsithe / Cruthaithe: (2024) -
Are payors ready for transparent prices yet?
de réir: Jasmin Barman-Aksözen
Foilsithe / Cruthaithe: (2022) -
Estimating the Impact of New Health Price Transparency Policies
de réir: Stephen T. Parente PhD
Foilsithe / Cruthaithe: (2023)